Scemlix
| Scemlix | |
|---|---|
| Term | Scemlix |
| Short definition | Scemlix - (pronounced) (SEM Blix) drug used to treat adults with chronic phase chronic myeloid leukemia that is Philadelphia chromosome positive. It is used in patients whose cancer has the T315I mutation or whose cancer has been treated with at least two other tyrosine kinase inhibitors. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Scemlix - (pronounced) (SEM Blix) drug used to treat adults with chronic phase chronic myeloid leukemia that is Philadelphia chromosome positive. It is used in patients whose cancer has the T315I mutation or whose cancer has been treated with at least two other tyrosine kinase inhibitors. It is also being studied in the treatment of other types of cancer. Scemblix blocks the BCR-ABL fusion protein, which can help prevent cancer cells from growing and kill them. Scemblix is a type of tyrosine kinase inhibitor. Also known as asciminib hydrochloride
External links
- Medical encyclopedia article on Scemlix
- Wikipedia's article - Scemlix
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski